|
Mar 20
|
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
|
|
Mar 20
|
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
|
|
Dec 5
|
TELA Bio to Take Part in Connecting the Dots
|
|
Nov 16
|
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
|
|
Aug 11
|
TELA Bio, Inc. (NASDAQ:TELA) Q2 2023 Earnings Call Transcript
|
|
Aug 10
|
Q2 2023 TELA Bio Inc Earnings Call
|
|
Aug 9
|
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 9
|
TELA Bio Reports Second Quarter 2023 Financial Results
|
|
Apr 30
|
TELA Bio, Inc. (NASDAQ:TELA) stock most popular amongst private equity firms who own 36%, while individual investors hold 26%
|
|
Apr 28
|
Dlocal and Augmedix Stock See Action From Activist Investors
|
|
Apr 27
|
TELA Bio to Announce First Quarter 2023 Financial Results
|